Perspective on Proteomics for Virus Detection in Clinical Samples

J Proteome Res. 2020 Nov 6;19(11):4380-4388. doi: 10.1021/acs.jproteome.0c00674. Epub 2020 Oct 22.

Abstract

One of the most widely used methods to detect an acute viral infection in clinical specimens is diagnostic real-time polymerase chain reaction. However, because of the COVID-19 pandemic, mass-spectrometry-based proteomics is currently being discussed as a potential diagnostic method for viral infections. Because proteomics is not yet applied in routine virus diagnostics, here we discuss its potential to detect viral infections. Apart from theoretical considerations, the current status and technical limitations are considered. Finally, the challenges that have to be overcome to establish proteomics in routine virus diagnostics are highlighted.

Keywords: COVID-19; PRM; SARS-CoV-2; mass spectrometry; parallel reaction monitoring; peptide selection; targeted mass spectrometry; targeted proteomics; virus diagnostics; virus proteomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Betacoronavirus / chemistry
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / virology
  • Humans
  • Mass Spectrometry / methods*
  • Pandemics
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / virology
  • Proteomics / methods*
  • Real-Time Polymerase Chain Reaction
  • SARS-CoV-2
  • Virology / methods*
  • Virus Diseases / diagnosis
  • Virus Diseases / virology